Researchers from Strategic BioSciences, together with investigators from the Institute for Asthma and Allergy (Wheaton, MD) reported that the new all-natural product is safe and effective in relieving symptoms of allergic rhinitis. MucoAd® is a mucoadhesive molecule (hypromellose) that prolongs contact with the nasal surface so that the nasal spray is well tolerated, lasts longer, and repeat dosing is needed less frequently.
prozac Read the rest of this entry »
Archive for June, 2009
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), announced the results of a wide-ranging animal study offering more evidence that Serdaxin™ may be an effective therapeutic for the treatment of anxiety disorders in humans. Serdaxin is Rexahn’s leading anxiety and depression drug candidate, and is currently in Phase II clinical trials.
The research tested Clavulanic acid, the primary compound in Serdaxin, Read the rest of this entry »
Researchers Compare Different Systems Of Measuring Treatment Intensity In Hypertension Care
22 Jun 2009
It is known that more intensive management of hypertension can improve blood pressure control and thus improve cardiovascular outcomes. However, there are several different systems of measuring the intensity of management of hypertension, and they have not been previously compared. If one system performs best, it would be important to use it to measure intensity of management for research and quality improvement Read the rest of this entry »
generic neurontin online buy With one in five, or 60 million, Americans suffering from some kind of allergy, spring and summer can be a difficult time of year as pollen, moisture and humidity increase. According to the Asthma and Allergy Foundation of America, allergies are considered the fifth leading chronic disease and are a major cause of work absenteeism, resulting Read the rest of this entry »
63 Percent Of RA Patients Suffer Psychiatric Disorders, With Depressive Spectrum Conditions Most Likely
20 Jun 2009
Over half (63%) of patients with rheumatoid arthritis (RA) also suffer from psychiatric disorders, with the majority of these (87%) occurring in the depressive spectrum, according to the results of a new study presented recently at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark. Interestingly, Read the rest of this entry »